In Vitro Activity of Sulbactam-Durlobactam against Global Isolates of Acinetobacter baumannii - calcoaceticus Complex Collected from 2016 to 2021

Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates From Greece

(2022) Dimitra Petropoulou et al.   Frontiers in Cellular and Infection Microbiology

Phenotypic and Molecular Characterisations of Carbapenem-resistant Acinetobacter baumannii Isolates Collected within the EURECA Study

(2021) T Kostyanev et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In vitro activity of sulbactam-durlobactam against extensive-drug-resistant Acinetobacter baumannii isolates belonging to South America major clones

(2021) Carolina S. Nodari et al.   Journal of Global Antimicrobial Resistance

Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam

(2021) Adam B. Shapiro et al.   Frontiers in Microbiology

In Vitro Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019

(2021) James A. Karlowsky et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activity of sulbactam-durlobactam against Acinetobacter baumannii-calcoaceticus complex isolates collected globally from 2016-2017

(2020) Sarah M. McLeod et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activity of sulbactam/durlobactam against clinical isolates of Acinetobacter baumannii collected in China

(2020) Qiwen Yang et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii

(2020) Harald Seifert et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)

(2019) Ana C Gales et al.   Open Forum Infectious Diseases

Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent

(2019) Melissa D. Barnes et al.   mBio

In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017

(2019) Ian Morrissey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

OUP accepted manuscript

(2018)   CLINICAL INFECTIOUS DISEASES

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

(2018) Evelina Tacconelli et al.   LANCET INFECTIOUS DISEASES

Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult Subjects

(2018) Keith A. Rodvold et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections

(2018) Burcu Isler et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

(2017) Thomas F. Durand-Réville et al.   Nature Microbiology

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

(2016) Andre C. Kalil et al.   CLINICAL INFECTIOUS DISEASES

Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges

(2016) Darren Wong et al.   CLINICAL MICROBIOLOGY REVIEWS

Molecular Mechanisms of Sulbactam Antibacterial Activity and Resistance Determinants in Acinetobacter baumannii

(2015) William F. Penwell et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii : Mechanisms and epidemiology

(2015) Anaïs Potron et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Dissemination of NDM Metallo-β-Lactamase Genes among Clinical Isolates of Enterobacteriaceae Collected during the SMART Global Surveillance Study from 2008 to 2012

(2014) D. Biedenbach et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Distinctive Attributes of β-Lactam Target Proteins inAcinetobacter baumanniiRelevant to Development of New Antibiotics

(2011) Seungil Han et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY